20 May, 2017
The Value Composite Two of Walgreens Boots Alliance, Inc. The mean target of $94.50 should be compared with the price when the stock was languishing around $74.71 a share. Brighton Jones LLC now owns 3,146 shares of the pharmacy operator's stock valued at $254,000 after buying an additional 38 shares during the last quarter. Walgreens Boots Alliance Inc has a 52-week low of $75.74 and a 52-week high of $89.69. Lazard Asset Management LLC now owns 7,680,077 shares of the pharmacy operator's stock worth $619,166,000 after buying an additional 4,457,421 shares during the last quarter.
In Drug Stores Industry, Walgreens Boots Alliance, Inc. Furthermore on 10/06/16 UBS "Initiates Coverage on" the stock to Buy. Great West Life Assurance Co.
03/22/2017 - Walgreens Boots Alliance, Inc. had its "buy" rating reiterated by analysts at Deutsche Bank. Shares have risen 0.88% over the trailing 6 months. Manitou Investment Management Ltd. raised its position in Walgreens Boots Alliance by 1.5% in the third quarter. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading. A total of 2.70 million shares exchanged hands as contrast to its average trading volume of 3.21 million shares. The company have shares float of 935.44 million.
Additionally on 10/31/16 Wells Fargo "Initiates Coverage On" Walgreens Boots Alliance (NASDAQ:WBA) to Outperform setting price target at $ and on 10/17/16 Jefferies "Upgrades" the stock to Buy.
Another critical number in evaluating a stock is P/E or the price to earnings ratio. Traders purchased 22,457 call options on the company. The average analysts gave this company a mean recommendation of 2.00.
According to analysts Walgreens Boots Alliance (NASDAQ:WBA)'s minimum EPS for the current quarter is at $1.22 and can go high up to $1.35.
Last time, the company shocked Wall Street by reporting EPS of $1.36, smashing the consensus of $1.36 per share. The firm had revenue of $29.45 billion for the quarter, compared to analysts' expectations of $30.17 billion. Looking further, Walgreens Boots Alliance, Inc. has a Gross Margin score of 37. The firm's revenue for the quarter was down 2.4% on a year-over-year basis. Equities analysts forecast that Walgreens Boots Alliance Inc will post $4.98 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 12th. Looking at some alternate time periods, the 12 month price index is 1.10336, the 24 month is 1.04856, and the 36 month is 1.32035. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date of this dividend is Tuesday, May 16th.
01/31/2017 - Walgreens Boots Alliance, Inc. had its "buy" rating reiterated by analysts at Evercore ISI. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & worldwide copyright and trademark law.
COPYRIGHT VIOLATION NOTICE: "Motco Lowers Position in Walgreens Boots Alliance Inc (WBA)" was first published by Chaffey Breeze and is owned by of Chaffey Breeze.
Several research firms have recently issued reports on WBA.
A price target is the projected price level of a financial security stated by an investment analyst. Zacks Investment Research cut shares of Walgreens Boots Alliance from a "buy" rating to a "hold" rating in a research report on Tuesday, January 31st. Guggenheim reaffirmed a "buy" rating and issued a $100.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, April 6th. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The company now has a consensus rating of "Buy" and a consensus price target of $91.77.
(PENN) stock moved with shift of 2.25% in the past week. Following the sale, the director now directly owns 21,887 shares in the company, valued at $1,879,874.43. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
And it remains to be seen which target price WBA can achieve without sacrificing much as the company is holding a 7.88% gain for the past twelve months. The Company is a global pharmacy-led, health and wellbeing enterprise. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.
